Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach(Radiogenomics-Liver)
NCT06536998 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2024-08-05
Summary
This is the prospective, observational cohort study (Radiogenomics-Liver), which aims to explore the relationship between the imaging information of liver cancer patients, tumor microenvironment and the prognosis of liver cancer patients.
Conditions
Sponsors & Collaborators
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-31
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- China
Study Locations
More Related Trials
-
Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer
NCT06194630 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC
NCT04984148 ·Status: UNKNOWN
-
Noninvasive Intratumor Heterogeneity Evaluation in HNSCC
NCT07027280 ·Status: RECRUITING
-
Clinical Significance of Computer Aided Image Analysis in Treatment Response Evaluation of Lung Cancer
NCT03954847 ·Status: UNKNOWN
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
NCT07118813 ·Status: RECRUITING
-
Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma
NCT05185544 ·Status: UNKNOWN
-
Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)
NCT07059923 ·Status: RECRUITING
-
Multi-dimensional Signatures for Precisely Predicting the Response and Prognosis of Lung Cancer Patients
NCT04980352 ·Status: UNKNOWN
-
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05636605 ·Status: RECRUITING
-
DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
NCT06755866 ·Status: RECRUITING ·Phase: NA
-
99mTc-H7ND SPECT/CT Imaging in NSCLC
NCT05999214 ·Status: RECRUITING ·Phase: NA
-
Radiomics for prEdiction of lunG cAncer biologY
NCT05819905 ·Status: UNKNOWN
-
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
NCT06756217 ·Status: RECRUITING
-
Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer
NCT02320617 ·Status: UNKNOWN ·Phase: NA
-
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
NCT04276025 ·Status: COMPLETED
-
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
NCT06742021 ·Status: RECRUITING ·Phase: NA
-
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)
NCT04923802 ·Status: TERMINATED
-
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
NCT07256002 ·Status: ACTIVE_NOT_RECRUITING
-
Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function
NCT03357094 ·Status: UNKNOWN
-
A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients
NCT06402981 ·Status: RECRUITING
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer
NCT03679936 ·Status: UNKNOWN